Anixa Biosciences stock price
애닉사 바이오사이언시스NASDAQ:ANIX · Nasdaq · Healthcare$2.95+6.50%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Anixa Biosciences last closed at $2.95 (+6.50%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -9.7×. Its overall grade ranks 516 of 739 stocks in Healthcare.
About this company
Anixa Biosciences last closed at $2.95 (+6.50%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 516/739
Valuation grade A
Related stocks
- AstraZenecaCompetitor
유방암·종양 면역치료 등 항암 파이프라인에서 경쟁 관계
- MerckCompetitor
면역항암제·암 치료제 개발 영역의 글로벌 경쟁사
- Bristol Myers SquibbCompetitor
암 치료제 및 면역항암제 시장에서 경쟁
About Anixa Biosciences
- What technical signals does Anixa Biosciences (ANIX) have?
- Anixa Biosciences current technical signals: no active technical signal.
- Is Anixa Biosciences a cup-and-handle pattern?
- No. Anixa Biosciences has no valid Cup signal right now.
- What published figures are available for Anixa Biosciences?
- Market cap: $97.1M. Trailing 12 months PER: -9.7×. Latest quarter PBR: 7.64×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Anixa Biosciences, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy